Oncodaily Talks #2, Part I: Dialogue with Giuseppe Curigliano, hosted by Chandler Park

Giuseppe Curigliano, MD PhD, is a Full Professor of Medical Oncology at the University of Milano and serves as the Chief of the Clinical Division of Early Drug Development at the European Institute of Oncology in Milan, Italy.
Dr. Curigliano is a renowned expert in advanced drug development for solid tumors, with a particular focus on breast cancer. He has played a significant role in developing numerous anticancer therapies that are now standard treatments for various solid tumors. He is a candidate for the presidency of the European Society for Medical Oncology (ESMO). ‪@EsmoOrgMedicalOncology‬

#oncodaily #esmo #mentorship #cancerresearch #breastcancer #clinicalresearch #oncology #cancer

00:00 Introduction
00:29 Being a mentor in the field of oncology
2:19 Prof. Curigliano's mission if he is elected ESMO president
5:50 Prof. Curigliano's personal journey in oncology
8:26 Experience in leadership
10:44 Precision medicine and AI in oncology

SUBSCRIBE to get the latest #oncodaily    / @oncodailytv  

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn:   / oncodaily  
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram:   / oncodailynews  
Follow OncoDaily on TikTok:   / oncodaily  
Like OncoDaily on Facebook:   / oncodaily  

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”